A 50-year-old nonhypertensive, nondiabetic, and nonalcoholic male presented with a history of unsteadiness of gait, confusion, and blurring of vision of 3 weeks. No history of recent febrile illness. No history of seizures. He was disoriented to time and place with impaired memory. He had horizontal gaze-evoked nystagmus with conjugate gaze palsy. Fundus was normal. Tandem gait was impaired with normal power and sensation in the upper and lower limbs. MRI brain revealed nearly symmetrical bilateral T2 and fluid-attenuated inversion recovery (FLAIR) hyperintensities in entire pons and midbrain including cerebral peduncles, thalami including pulvinar and periventricular areas of third ventricle, anterior thalamo-capsulo-ganglionic regions, corona radiata, genu and proximal body of corpus callosum extending into the centrum semiovale on the left side, anterior to the fourth ventricle, and in the periaqueductal region [ Figures 1-3 ]. There was subtle diffusion restriction and contrast study revealed focal enhancement in the left cerebral peduncle and right half of splenium of corpus callosum.
[ Figures 4 and 5] . Laboratory investigations, including blood glucose, serum creatine, electrolytes, and liver function tests, were within normal limits. Antinuclear antibodies were negative, and he had nonreactive HIV-1 and HIV-2 antibody tests. Whole body 18 fluorodeoxyglucose positron-emission tomography-computed tomography (CT) scan showed no metabolically active lesions. CSF analysis was unremarkable. WE was suspected, and therapeutic doses of parenteral thiamine were administered. Craniotomy with biopsy from corpus callosal lesion was done to exclude the differentials including diffuse glioma with gliomatosis cerebri pattern of spread. Histopathological examination revealed focal areas of hemorrhage and blackish pigmentation [ Figure 6 ]. No evidence of demyelination or neoplasia. It was concluded to be consistent with WE. Postbiopsy follow-up MRI 1 week after initiation of the treatment revealed similar findings as the initial scan. The patient recovered partially over next 2 weeks. Based on the typical clinical features, supportive biopsy findings, ruling out possible differentials, and clinical improvement with parenteral thiamine the final diagnosis of WE was made.
WE is a potentially treatable neurological emergency. A high index of suspicion is required given atypical clinical and imaging features. CT is not much of use in the diagnosis of WE. Typical MRI findings in WE include symmetrical T2 and fluid-attenuated inversion recovery hyperintensities in thalami, periventricular areas of the third ventricle, periaqueductal area,
Wernicke Encephalopathy with Atypical Findings on Magnetic
Resonance Imaging mammillary bodies, and tectal plate and in the periventricular gray matter located anteriorly to the fourth ventricle with enhancement on contrast. T1 postcontrast imaging is recommended in suspected cases of WE even when the plain study is negative. [2, 3] Mammillary bodies are not involved in our case. Atypical MRI findings have been variably described in the previous studies with symmetrical signal changes in the cerebellum, vermis, dorsal medulla, pons, red nuclei, cranial nerve nuclei, splenium of corpus callosum, and cerebral cortex and are usually associated with typical findings. [4, 5] Atypical MRI findings are more common in nonalcoholic patients but have also been seen in alcoholics. [5] The present case highlights the atypical imaging features of WE and empirical treatment with parenteral thiamine may be considered in patients with suggestive clinical features, pending the definitive diagnosis.
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The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Sir, We read with interest the article titled, " Long-term response of cerebrospinal fluid pressure in patients with idiopathic intracranial hypertension: A prospective observational study" by Gafoor et al. [1] We appreciate the authors effort and their research. We would like to highlight few points regarding (i) the interaction between intraocular pressure (IOP) and intracranial pressure (ICP) in idiopathic intracranial hypertension (IIH), (ii) the presence or absence of papilledema in IIH, and (iii) the importance of visual function assessment in IIH.
In Gafoor et al. ' s [1] case series, a subset of four IIH patients did not have papilledema at onset. All the patients in this study received acetazolamide and frusemide. Our assumption is that probably they developed papilledema during the course of disease. This is an important observation from neuro-ophthalmic perspective. This subset of patients (absent papilledema at onset of IIH) might have had elevated IOP due to preexisting, undetected glaucoma. Due to diurnal variation of IOP, a single reading might miss raised IOP. Acetazolamide-induced IOP reduction would have changed ICP/IOP pressure gradient, resulting in the development of papilledema. IOP may be an important factor in optic disc swelling. [2] Lowering IOP may "unmask" disc swelling from elevated ICP, altering the translaminar pressure gradient. Vomiting is a common feature of elevated ICP. Vomiting-induced Valsalva maneuver (VM) may cause elevated IOP even in normal individuals. [3] Hence, VM-induced IOP elevation would have contributed to masking of papilledema in this subset of IIH patients.
Usual practice in perimetry is to perform standard automated perimetry 30-2 (SAP) to document visual loss in IIH. This perimetry measures visual field loss within central 30°. Kinetic perimetry is ideal for documenting visual field loss beyond central 30°. SAP is suitable for diagnosing glaucoma. In IIH, loss of visual function is the early serious complication. Visual acuity, peripheral, and central fields should all be sequentially recorded. [4] The visual loss is usually insidious and often asymptomatic for long periods of time, and visual disaster can only be anticipated by monitoring the visual fields and acuity. To conclude, IOP should be periodically evaluated in IIH patients, who present with asymmetrical papilledema or if papilledema develops following acetazolamide therapy.
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